Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Dolby Laboratories Temettü

Temettü kriter kontrolleri 5/6

Dolby Laboratories kazançlarla iyi bir şekilde karşılanan, 1.58% cari getiriye sahip, temettü ödeyen bir şirkettir.

Anahtar bilgiler

1.6%

Temettü verimi

54%

Ödeme oranı

Sektör ortalama getirisi0.8%
Bir sonraki temettü ödeme tarihin/a
Eski temettü tarihin/a
Hisse başına temettüUS$1.200
Hisse başına kazançUS$2.23
Temettü verim tahmini1.6%

Son temettü güncellemeleri

Recent updates

Is There Now An Opportunity In Dolby Laboratories, Inc. (NYSE:DLB)?

Sep 22
Is There Now An Opportunity In Dolby Laboratories, Inc. (NYSE:DLB)?

Dolby Laboratories: Need To See Improvements In Sales Before Committing Capital

Aug 22

Dolby Laboratories, Inc.'s (NYSE:DLB) Share Price Matching Investor Opinion

Aug 13
Dolby Laboratories, Inc.'s (NYSE:DLB) Share Price Matching Investor Opinion

We Like These Underlying Return On Capital Trends At Dolby Laboratories (NYSE:DLB)

Jul 26
We Like These Underlying Return On Capital Trends At Dolby Laboratories (NYSE:DLB)

Dolby Laboratories: A Sound Player, Trading At A Too-Rich Valuation

Jun 10

Should You Think About Buying Dolby Laboratories, Inc. (NYSE:DLB) Now?

Jun 07
Should You Think About Buying Dolby Laboratories, Inc. (NYSE:DLB) Now?

Dolby Laboratories Remains A Hold

May 14

Dolby Laboratories, Inc. (NYSE:DLB) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

May 05
Dolby Laboratories, Inc. (NYSE:DLB) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Dolby Laboratories, Inc.'s (NYSE:DLB) Earnings Haven't Escaped The Attention Of Investors

May 02
Dolby Laboratories, Inc.'s (NYSE:DLB) Earnings Haven't Escaped The Attention Of Investors

Investors Will Want Dolby Laboratories' (NYSE:DLB) Growth In ROCE To Persist

Apr 16
Investors Will Want Dolby Laboratories' (NYSE:DLB) Growth In ROCE To Persist

Dolby Laboratories, Inc. (NYSE:DLB) Shares Could Be 26% Below Their Intrinsic Value Estimate

Mar 17
Dolby Laboratories, Inc. (NYSE:DLB) Shares Could Be 26% Below Their Intrinsic Value Estimate

Dolby Laboratories Sees Flat Revenue Ahead (Downgrade)

Mar 01

Dolby Laboratories' (NYSE:DLB) Earnings Offer More Than Meets The Eye

Feb 09
Dolby Laboratories' (NYSE:DLB) Earnings Offer More Than Meets The Eye

What Is Dolby Laboratories, Inc.'s (NYSE:DLB) Share Price Doing?

Jan 31
What Is Dolby Laboratories, Inc.'s (NYSE:DLB) Share Price Doing?

With Dolby Laboratories, Inc. (NYSE:DLB) It Looks Like You'll Get What You Pay For

Jan 15
With Dolby Laboratories, Inc. (NYSE:DLB) It Looks Like You'll Get What You Pay For

The Return Trends At Dolby Laboratories (NYSE:DLB) Look Promising

Dec 28
The Return Trends At Dolby Laboratories (NYSE:DLB) Look Promising

Dolby Laboratories: On A Positive Hold As Shareholder Rewards Continue

Dec 06

A Look At The Fair Value Of Dolby Laboratories, Inc. (NYSE:DLB)

Nov 18
A Look At The Fair Value Of Dolby Laboratories, Inc. (NYSE:DLB)

At US$81.66, Is Dolby Laboratories, Inc. (NYSE:DLB) Worth Looking At Closely?

Oct 11
At US$81.66, Is Dolby Laboratories, Inc. (NYSE:DLB) Worth Looking At Closely?

Dolby Laboratories: High P/E Is Not Justified, A Hold For Now

Sep 13

The Returns At Dolby Laboratories (NYSE:DLB) Aren't Growing

Aug 03
The Returns At Dolby Laboratories (NYSE:DLB) Aren't Growing

What Is Dolby Laboratories, Inc.'s (NYSE:DLB) Share Price Doing?

Jul 12
What Is Dolby Laboratories, Inc.'s (NYSE:DLB) Share Price Doing?

Dolby Laboratories Sees Return To Growth Ahead

Jun 22

Returns On Capital At Dolby Laboratories (NYSE:DLB) Paint A Concerning Picture

May 04
Returns On Capital At Dolby Laboratories (NYSE:DLB) Paint A Concerning Picture

A Look At The Intrinsic Value Of Dolby Laboratories, Inc. (NYSE:DLB)

Apr 14
A Look At The Intrinsic Value Of Dolby Laboratories, Inc. (NYSE:DLB)

Is There Now An Opportunity In Dolby Laboratories, Inc. (NYSE:DLB)?

Mar 29
Is There Now An Opportunity In Dolby Laboratories, Inc. (NYSE:DLB)?

Dolby Laboratories goes ex-dividend on Monday

Feb 10

Dolby Laboratories FQ1 2023 Earnings Preview

Feb 01

Dolby Laboratories (NYSE:DLB) Could Be At Risk Of Shrinking As A Company

Jan 24
Dolby Laboratories (NYSE:DLB) Could Be At Risk Of Shrinking As A Company

Dolby: A 2023 Update, And Still A 'Hold'

Jan 11

An Intrinsic Calculation For Dolby Laboratories, Inc. (NYSE:DLB) Suggests It's 25% Undervalued

Jan 09
An Intrinsic Calculation For Dolby Laboratories, Inc. (NYSE:DLB) Suggests It's 25% Undervalued

Is Dolby Laboratories, Inc. (NYSE:DLB) Potentially Undervalued?

Dec 25
Is Dolby Laboratories, Inc. (NYSE:DLB) Potentially Undervalued?

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: DLB şirketinin hisse başına düşen temettüsü son 10 yıldır istikrarlıydı.

Büyüyen Temettü: DLB şirketinin temettü ödemeleri son 10 yıldır artış göstermektedir.


Piyasaya Karşı Temettü Getirisi

Dolby Laboratories Piyasaya Karşı Temettü Getirisi
DLB temettü verimi piyasa ile karşılaştırıldığında nasıldır?
SegmentTemettü Verimi
Şirket (DLB)1.6%
Pazarın Alt %25'i (US)1.4%
Pazarın En İyi %25'i (US)4.4%
Sektör Ortalaması (Software)0.8%
Analist tahmini (DLB) (3 yıla kadar)1.6%

Önemli Temettü: DLB 'in temettüsü ( 1.58% ), US piyasasındaki temettü ödeyenlerin en alttaki %25'inden ( 1.42% ) daha yüksektir.

Yüksek Temettü: DLB 'in temettüsü ( 1.58% ), US piyasasındaki temettü ödeyenlerin en üst %25'ine ( 4.33% ) kıyasla düşüktür.


Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: Makul ödeme oranı ( 54% ) ile DLB 'un temettü ödemeleri kazançlarla karşılanmaktadır.


Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: Oldukça düşük nakit ödeme oranı ( 43.1% ) ile DLB 'un temettü ödemeleri nakit akışları tarafından iyi bir şekilde karşılanmaktadır.


Güçlü temettü ödeyen şirketleri keşfedin